Cerus (CERS) Total Current Liabilities (2010 - 2026)
Cerus (CERS) posted Total Current Liabilities of $85.8 million for Q2 2026, down 20.11% sequentially from $107.4 million in Q1 2026, and up 1.7% YoY from $84.4 million in Q2 2025.
Cerus (CERS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Cerus has reported Total Current Liabilities for 17 years, with the latest figure at $85.8 million in Q2 2026.
- Quarterly Total Current Liabilities rose 1.7% year-over-year to $85.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $85.8 million (up 1.7% YoY) and the FY2025 annual result came in at $100.8 million, up 58.47% from the prior year.
- Total Current Liabilities retreated to $85.8 million in Q2 2026 per CERS's latest filing, from $107.4 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $117.1 million in Q4 2022 and troughed at $53.9 million in Q2 2024.
- A 5-year average of $79.1 million and a median of $78.4 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities slumped 42.32% in 2023, then surged 62.73% in 2025.
- Over 5 years, Total Current Liabilities stood at $117.1 million in 2022, then plunged by 42.32% to $67.5 million in 2023, then fell by 5.8% to $63.6 million in 2024, then soared by 58.47% to $100.8 million in 2025, then declined by 14.89% to $85.8 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $85.8 million, $107.4 million, and $100.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 85.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.79 Mn |
| Mar 31, 2026 | 107.38 Mn |
| Dec 31, 2025 | 100.80 Mn |
| Sep 30, 2025 | 88.43 Mn |
| Jun 30, 2025 | 84.36 Mn |
| Mar 31, 2025 | 69.69 Mn |
| Dec 31, 2024 | 63.61 Mn |
| Sep 30, 2024 | 54.35 Mn |
| Jun 30, 2024 | 53.88 Mn |
| Mar 31, 2024 | 57.25 Mn |
| Dec 31, 2023 | 67.52 Mn |
| Sep 30, 2023 | 80.12 Mn |
| Jun 30, 2023 | 75.08 Mn |
| Mar 31, 2023 | 77.57 Mn |
| Dec 31, 2022 | 117.06 Mn |
| Sep 30, 2022 | 95.02 Mn |
| Jun 30, 2022 | 79.28 Mn |
| Mar 31, 2022 | 66.66 Mn |
| Dec 31, 2021 | 78.56 Mn |
| Sep 30, 2021 | 64.72 Mn |